Patients undergoing tooth extraction while on anticoagulant therapy present a difficult bleeding-control challenge for oral surgeons. Although routine extractions are largely standardized, postoperative hemorrhage remains a key perioperative risk, and conventional gauze pressure or suturing is not always sufficient in high-risk cases. A systematic review published in The Journal of the American Dental Association now points to topical hemostatic agents as a potentially more effective adjunct.
The bleeding challenge after extraction
Tooth extraction is among the most frequent procedures in oral and maxillofacial surgery. The operation is relatively standardized, but perioperative complications remain possible, and postoperative bleeding is a persistent concern in clinical management.
Conventional hemostatic methods, including gauze compression and suturing, generally perform well in healthy patients. In certain high-risk groups, however, these traditional approaches often fall short of the desired result.
Higher risk in anticoagulated patients
Patients receiving oral antithrombotic therapy or those with coagulation disorders face a substantially elevated risk of bleeding after extraction. Clinicians need targeted adjunctive interventions that preserve surgical safety while shortening time to hemostasis and reducing postoperative bleeding events.
Topical hemostatic gels and related local agents have emerged as one option for addressing this clinical gap, though their use should be considered alongside standard care and professional judgment.
What the clinical evidence shows
The systematic review examined randomized clinical trials identified through Medline, Scopus, and the Cochrane databases. Researchers compared the performance of topical hemostatic agents with conventional hemostatic methods.
The data indicated that topical agents were associated with significant advantages in shortening bleeding time and lowering the incidence of postoperative bleeding. The effect was observed in both healthy patients and those receiving anticoagulation therapy.
| Outcome | Healthy patients | Patients on anticoagulation therapy |
|---|---|---|
| Bleeding time reduction (SMD) | -1.02 (95% CI: -1.70 to -0.35) | -2.30 (95% CI: -3.20 to -1.39) |
| Bleeding event risk (HR) | Significant reduction (P=0.007) | Significant reduction (P=0.007) |
Applying topical agents in practice
Evidence reviewed in the study covered multiple topical formats, including gels, mouth rinses, and hemostatic-agent-impregnated gauze. Each was reported to be superior to conventional compression for reducing postoperative bleeding.
For patients on anticoagulation therapy, the findings suggest that topical hemostatic gels may be particularly useful as an adjunct to routine measures. Their coverage and biocompatibility support careful use in postoperative management, but clinical decisions should remain individualized.
